Last reviewed · How we verify
NCT04851548
Evaluate the Effect of Hyaluronic Acid in the Treatment of Furcation Involvement
NA trial testing hyaluronic acid in Furcation Defects in 18 participants. Status unknown.
20 September 2022
Quick facts
| Lead sponsor | Riyadh Elm University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 18 |
| Start date | 23 September 2021 |
| Primary completion | 20 September 2022 |
| Estimated completion | 20 September 2022 |
Drugs / interventions tested
- hyaluronic acid (HYALURONIC ACID) — full drug profile →
Conditions studied
- Furcation Defects — all drugs for Furcation Defects →
Sponsor
Riyadh Elm University
Who can join
Adults 18 to 55, any sex, with Furcation Defects. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the effect Hyaluronic Acid in the Treatment of Furcation Involvement
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04851548
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of hyaluronic acid
Trials testing the same drug.
- NCT05983081 — Efficacy of Intra-articular Hyaluronate Injection for Adhesive Capsulitis · NA · completed
- NCT06814769 — Hyaluronic Acid and Articular Pain · completed
- NCT06693739 — Regenerative Ability of Immature Necrotic Permanent Teeth Using Different Scaffolds · NA · active not recruiting
- NCT05027581 — Chondrochymal® for Subjects With Knee Osteoarthritis (Knee OA) · Phase 2 · completed
- NCT04586361 — Prospective Analysis of Introperative RegenLab PRP and Hyaluronic Acid in Patients With Knee ACL Tear · Phase 4 · unknown
Other recruiting trials for Furcation Defects
Currently open trials in the same condition.
- NCT06270303 — Use of a Bone Substitute Material in the Surgical Therapy of Furcation Defects · NA · recruiting
Other Riyadh Elm University trials
Trials by the same sponsor.
- NCT07397871 — Salivary Flow, pH, and Buffering Capacity in Fixed and Clear Aligner Orthodontic Treatment · NA · not yet recruiting
- NCT06503029 — Evaluate Cytotoxicity, Leaching, and Structural Conformation of Clear Aligners · Phase 4 · not yet recruiting
- NCT06161714 — The Effectiveness of Buccal Infiltration Only Using Articaine for Extraction of Mandibular Molar · Phase 4 · unknown
- NCT06093256 — Taste Changes With Fixed Orthodontic Appliances · unknown
- NCT06790433 — Comparison Between the Dentapen and Vibraject · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04851548 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Riyadh Elm University
- Last refreshed: 17 September 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04851548.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing